Pohl Boskamp patents expiration
1. Gonitro patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9101592 | POHL BOSKAMP | Stabilized granules containing glyceryl trinitrate |
Mar, 2032
(8 years from now) | |
Drugs and Companies using NITROGLYCERIN ingredient
Market Authorisation Date: 08 June, 2016
Treatment: NA
Dosage: POWDER;SUBLINGUAL
More Information on Dosage
GONITRO family patents
2. Nitrolingual patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7872049 | POHL BOSKAMP | Long-term stable pharmaceutical preparation containing the active ingredient glyceryl trinitrate |
Mar, 2029
(5 years from now) | |
Drugs and Companies using NITROGLYCERIN ingredient
Market Authorisation Date: 31 October, 1985
Treatment: Method of treating angina pectoris
Dosage: SPRAY, METERED;SUBLINGUAL
How can I launch a generic of NITROLINGUAL before it's drug patent expiration?
More Information on Dosage
NITROLINGUAL family patents
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic